Table 1. Left ventricular function measured by echocardiography and infarct size among groups 7 days after CPCs transplantation.
Control | Nx | Hx | Hx+AMD | |
LVEF (%) | 30.5±3.7 | 44.7±3.1* | 54.9±4.5* | 43.7±3.7* |
LVFS (%) | 14.3±2.0 | 21.9±1.6* | 27.9±2.8* | 21.3±1.8* |
Infarct size (%) | 49.6±5.9 | 37.9±5.0* | 25.8±5.4* § | 37.5±3.7* |
BW(g) | 23.3±0.9 | 23.3±0.4 | 24.8±0.6# | 23.6±0.9 |
HW(mg) | 132.6±11.1 | 127.4±6.6 | 117.0±10.4 | 127.2±7.4 |
HW/BW(mg/g) | 5.7±0.4 | 5.5±0.3 | 4.7±0.4* § | 5.4±0.5 |
Date represented as mean ± SD; n = 5 in each group.
Nx normoxia, Hx hypoxia, AMD AMD3100, LVEF left ventricular ejection fraction, LVFS left ventricular fractional shortening, BW body weight, HW heart weight, HW/BW heart weight/body weight.
P<0.01 vs. Control
P<0.05 vs. Nx and Hx + AMD
P<0.05 vs. Control and Nx.